These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28807470)

  • 41. The ACCP guidelines for thromboprophylaxis in total hip and knee arthroplasty.
    Colwell CW
    Orthopedics; 2009 Dec; 32(12 Suppl):67-73. PubMed ID: 20201479
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for thromboprophylaxis in lower joint arthroplasty.
    Colwell CW
    Am J Orthop (Belle Mead NJ); 2007 Sep; 36(9 Suppl):11-3. PubMed ID: 17948162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Efficacy and safety of aspirin in prevention of venous thromboembolism after total joint arthroplasty].
    Tian H; Song F; Zhang K; Liu Y
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(47):3349-52. PubMed ID: 18478950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials.
    Dentali F; Mumoli N; Prisco D; Fontanella A; Di Minno MN
    Thromb Haemost; 2017 Feb; 117(3):606-617. PubMed ID: 28078350
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apixaban versus enoxaparin in patients with total knee arthroplasty. A meta-analysis of randomised trials.
    Huang J; Cao Y; Liao C; Wu L; Gao F
    Thromb Haemost; 2011 Feb; 105(2):245-53. PubMed ID: 20941455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of venous thromboprophylaxis duration and outcomes in orthopedic patients.
    Wells PS; Borah BJ; Sengupta N; Supina D; McDonald HP; Kwong LM
    Am J Manag Care; 2010 Nov; 16(11):857-63. PubMed ID: 21348557
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors.
    Parvizi J; Huang R; Raphael IJ; Arnold WV; Rothman RH
    Clin Orthop Relat Res; 2014 Mar; 472(3):903-12. PubMed ID: 24264881
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery.
    Colwell C; Mouret P
    Semin Vasc Med; 2005 Aug; 5(3):266-75. PubMed ID: 16123914
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Timing of Symptomatic Pulmonary Embolism in Patients With Nonwarfarin Anticoagulants Following Elective Primary Total Joint Arthroplasty.
    Hu C; Liu C; Wang Y; Ding T; Sun K; Tian S
    J Arthroplasty; 2020 Jun; 35(6):1703-1707. PubMed ID: 32046872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of rivaroxaban for chemical thromboprophylaxis following total knee replacement.
    Rath NK; Goodson MW; White SP; Forster MC
    Knee; 2013 Dec; 20(6):397-400. PubMed ID: 23566737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venous Thromboembolic Disease in Revision vs Primary Total Knee Arthroplasty.
    Boylan MR; Perfetti DC; Kapadia BH; Delanois RE; Paulino CB; Mont MA
    J Arthroplasty; 2017 Jun; 32(6):1996-1999. PubMed ID: 28209273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Venous thromboembolic disease after total hip and knee arthroplasty.
    Haas SB; Barrack RL; Westrich G; Lachiewicz PF
    J Bone Joint Surg Am; 2008 Dec; 90(12):2764-80. PubMed ID: 19047723
    [No Abstract]   [Full Text] [Related]  

  • 54. Pneumatic compression with foot pumps facilitates early postoperative mobilisation in total knee arthroplasty.
    Windisch C; Kolb W; Kolb K; Grützner P; Venbrocks R; Anders J
    Int Orthop; 2011 Jul; 35(7):995-1000. PubMed ID: 20652250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis.
    Kanchanabat B; Stapanavatr W; Meknavin S; Soorapanth C; Sumanasrethakul C; Kanchanasuttirak P
    Br J Surg; 2011 Oct; 98(10):1356-64. PubMed ID: 21674473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
    Asopa V; Cobain W; Martin D; Keene G; Bauze A
    ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improve the results of phase II trials of thromboprophylaxis with the new oral anticoagulant drugs.
    Zufferey PJ; Samama CM; Rosencher N
    Thromb Haemost; 2010 Dec; 104(6):1083-4. PubMed ID: 20886198
    [No Abstract]   [Full Text] [Related]  

  • 58. Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study.
    Bedair H; Berli M; Gezer S; Jacobs JJ; Della Valle CJ
    Clin Orthop Relat Res; 2011 Jan; 469(1):131-7. PubMed ID: 20824408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hospital charges associated with "never events": comparison of anterior cervical discectomy and fusion, posterior lumbar interbody fusion, and lumbar laminectomy to total joint arthroplasty.
    Daniels AH; Kawaguchi S; Contag AG; Rastegar F; Waagmeester G; Anderson PA; Arthur M; Hart RA
    J Neurosurg Spine; 2016 Aug; 25(2):165-9. PubMed ID: 26989978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The attempt of identification of the essentials risk factors of venous thromboembolism after hip arthroplasty despite of pharmacological prophylaxis].
    Radziejewicz P; Gregosiewicz A; Bednarek A; Siczek M
    Chir Narzadow Ruchu Ortop Pol; 2010; 75(4):242-7. PubMed ID: 21375033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.